[Ligandomics--a tool for the development of targeted treatments].
Porkka
Kimmo
K
HUS, sisätautien toimiala, hematologian klinikka. kimmo.porkka@hus.fi
Laakkonen
Pirjo
P
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D020650:Combinatorial Chemistry Techniques; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D008024:Ligands; D009369:Neoplasms / Q000188:drug therapy; D019151:Peptide Library; D010455:Peptides / Q000138:chemical synthesis / Q000627:therapeutic use; D025941:Protein Interaction Mapping / Q000379:methods* / Q000639:trends*; D040901:Proteomics / Q000379:methods*
D000970:Antineoplastic Agents; D008024:Ligands; D019151:Peptide Library; D010455:Peptides